Nephrogenic Systemic Fibrosis Lawyer

Loading...

Sign in or sign up now!
Alert icon
Upgrade to the latest Flash Player for improved playback performance. Upgrade now or more info.
649 views
Loading...
Alert icon
Sign in or sign up now!
Alert icon

Uploaded by on Mar 11, 2010

A dye used in MRI (magnetic resonance imaging) and MRA (magnetic resonance angiography) scans has been linked to a rare and potentially fatal skin disease in some users. The problem stems from the metal gadolinium found in the dyes injected into some patients before MRI scans and all patients before MRA scans.

The disease is known as nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy (NSF/NFD), and appears to only occur in patients with kidney disease who undergo an MRI or MRA where a gadolinium-based dye is used (1). Most recently, the medical community, in recognizing the established link between NSF and gadolinium dyes, has started referring to the condition as gadolinium-associated systemic fibrosis, or GASF.

Our law firm is actively investigating cases of patients administered a gadolinium-based contrast dye who later suffered from nephrogenic systemic fibrosis or nephrogenic fibrosing dermopathy (NSF/NFD). We want to help. Call us today.

  • likes, 0 dislikes

Link to this comment:

Share to:
see all

All Comments (0)

Sign In or Sign Up now to post a comment!
Loading...

Alert icon
0 / 00Unsaved Playlist Return to active list
    1. Your queue is empty. Add videos to your queue using this button:
      or sign in to load a different list.
    Loading...Loading...Saving...
    • Clear all videos from this list
    • Learn more